FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
117 letters match. Newest first.
-
DevicesNext Medical Products Company, LLC
FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.
High risk -
DrugsNorthland Nuclear Medicine, LLC
FDA warned Northland Nuclear Medicine in Bismarck, ND, that its PET drugs are adulterated because it failed to investigate microbial contamination and low yields.
High risk -
DrugsSnugZ USA, Inc.
SnugZ USA, an OTC drug maker in West Jordan, Utah, was cited for releasing drugs after retesting failed batches until they passed.
High risk -
DrugsHanlim Pharm Co., Ltd.
FDA warned Hanlim Pharm over serious sterile manufacturing violations, including poor aseptic practices and airflow problems, at its South Korea plant.
High risk -
FoodOcean Pride Seafood, Inc.
FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.
High risk -
DrugsWalmart, Inc.
Walmart sold three unapproved drugs for genital herpes and sores on walmart.com, FDA says.
High risk -
FoodStar Ocean Wholesale Foods, Inc.
FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.
High risk -
FoodTipical Latin Food, Corp. DBA La Pradera
FDA warned La Pradera of Doral, Florida, that its ready-to-eat Venezuelan-style cheeses are adulterated; an inspection found no food safety plan and pests.
High risk -
DrugsHappy Farm Botanicals, Inc.
Happy Farm Botanicals, an OTC drug maker in Hyattsville, MD, cited for skipping ingredient identity tests and stability testing, repeat violations.
High risk -
DrugsTXP Innovations LLC dba Tex Peptides
FDA warned Dallas peptide seller TXP Innovations (Tex Peptides) that its website sells unapproved injectable drugs, including semaglutide and tirzepatide.
High risk -
DrugsEugia Pharma Specialities Limited
FDA warned Eugia Pharma Specialities that flawed aseptic line design and poor aseptic practices at its Kolthur Village plant risk contaminating sterile injectables.
High risk -
AnimalDeJong Family Dairy, LLC
FDA warned DeJong Family Dairy that it treated cows with an animal drug in ways the label and a veterinarian did not allow.
Medium -
FoodAF Import & Wholesale Co
FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.
High risk -
DrugsPure Arylcyclohexylamine Store / www.arylcyclohexylamine.com
FDA warned Pure Arylcyclohexylamine Store it sells unapproved, misbranded ketamine drugs, including an injectable, to U.S. consumers online.
High risk -
DrugsKetamine Troche Store / www.ketaminetrochestore.com
FDA warned online seller Ketamine Troche Store that its website sells unapproved, misbranded ketamine drugs without prescriptions.
High risk -
DrugsKetamine Store / www.ketaminestore.org
FDA warned website Ketamine Store for selling unapproved, misbranded ketamine liquid and compounded products online without prescriptions.
High risk -
DrugsKetdaxandrugs / www.ketdaxandrugs.org
FDA warned Ketdaxandrugs it sells unapproved, misbranded ketamine "KETAMINE CRYSTAL" online without prescriptions to U.S. consumers.
High risk -
DevicesSkytron, LLC
Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.
High risk -
DrugsTelos Trading Limited dba Alwinshop
FDA warns UK online seller Alwinshop that its "Prostatitis Remission Cream" is an unapproved, misbranded drug with false FDA endorsement claims.
High risk -
FoodJMT Inter LLC
FDA warned Delaware food importer JMT Inter LLC for not keeping or sending required records on imported soft drinks.
Medium -
FoodISA Produce Corporation
ISA Produce Corporation lacked FSVP records for imported fresh produce, FDA says after February 2026 inspection.
High risk -
FoodNaumes, Inc.
FDA warned Naumes, Inc. that its pears may have been contaminated with filth after an inspection found produce-safety violations.
High risk -
DrugsThrive Health and Wellness, LLC dba Thrive Health Solutions
FDA warned Thrive Health and Wellness, a Colorado repackager, that sterile drugs were made in unsanitary conditions and sold without approval.
High risk -
FoodA TO Z Distributor Inc
FDA warns Brooklyn food importer A TO Z Distributor for having no foreign supplier verification program for any imported food.
Medium -
FoodEl Rey USA Meats & Seafood Inc.
FDA found El Rey USA Meats & Seafood lacked required importer verification for shrimp and tilapia.
High risk -
DrugsGood Girl LLC dba GoodGirlRX
FDA warns telehealth seller GoodGirlRX that its website misbrands compounded semaglutide and tirzepatide, claiming FDA approval and implying it is the compounder.
Medium -
DrugsBertrand P. Cole, D.O.
FDA warns Dr. Bertrand P. Cole that he gave four trial subjects too much drug by not following the study plan.
High risk -
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsLouisville Reproductive Center
Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.
High risk -
DrugsSignature Formulations, LLC
FDA says Signature Formulations made OTC drugs on shared equipment without adequate controls, risking hormone contamination.
High risk -
DrugsWinder Laboratories, LLC
FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.
High risk -
DrugsTower Laboratories Ltd.
FDA warned Tower Laboratories, an OTC drug maker in Montague, MI, for weak out-of-specification investigations and unproven test methods.
High risk -
DevicesFlux Lab Pte. Ltd. d/b/a The Fluxion
FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.
Medium -
BiologicsGreen Valley Fertility Partners
FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.
High risk -
DevicesHong Qiangxing Shenzhen Electronics Limited
FDA warned Hong Qiangxing Shenzhen Electronics after an inspection found quality-system violations in TENS, muscle stimulator, and blood pressure monitor manufacturing.
Medium -
DrugsMiers Laboratories, Ltd
FDA warns Miers Laboratories over manufacturing violations and places import alert on its drugs.
High risk -
DrugsCelestaPro
FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.
High risk -
DevicesQianjiang Kingphar Medical Material Co Ltd.
FDA warned Chinese device maker Qianjiang Kingphar that dirty cleanrooms and weak environmental controls make its masks, dressings, wraps and drapes adulterated.
High risk -
DrugsDixon Investments Inc. dba ARI
FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.
High risk -
FoodTime Challenger Labs International, Inc.
Time Challenger Labs was warned for unapproved drug claims on five supplements and serious manufacturing violations.
High risk -
DrugsHims & Hers Health, Inc. dba Hers
FDA warned Hims & Hers (Hers) that its website misleads consumers about compounded semaglutide by implying it is the same as approved Ozempic and Wegovy.
Medium -
DrugsVitals RX
FDA warned telehealth seller Vitals RX that its website falsely implies compounded semaglutide and tirzepatide are the approved drug Ozempic.
Medium -
DrugsSlendid
FDA warned Slendid that its website sells compounded semaglutide and tirzepatide with a false "clinically proven" claim, making the drugs misbranded.
Medium -
DrugsBiopreventative Company LLC dba Biopreventative
FDA told Biopreventative its website claim that compounded tadalafil is "commonly known as Cialis" misbrands the drug.
Low -
DrugsSprout Health Partners LLC dba Sprout Health
FDA warned telehealth seller Sprout Health that its website's claim compounded semaglutide and tirzepatide are FDA-approved makes the drugs misbranded.
Low -
DrugsTRYM Health, Inc. dba TRYM Health
FDA told telehealth seller TRYM Health its website claims for compounded semaglutide and tirzepatide are false and misleading, making the drugs misbranded.
Medium -
DrugsEvoLife Wellness
FDA warned EvoLife Wellness that its website wrongly calls compounded semaglutide and tirzepatide "FDA-Approved," making the drugs misbranded.
Medium -
DevicesLeMaitre Vascular, Inc.
LeMaitre Vascular's Artegraft graft plant in New Jersey drew an FDA warning letter for water, sterilization and recall-reporting failures.
High risk -
DevicesUscom Kft
Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.
High risk -
DrugsABBE Laboratories, Inc.
FDA warns ABBE Laboratories over manufacturing failures for over-the-counter topical drugs, including ingredient testing.
High risk